Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $16.00 + 0.14
February 17, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q3 2016 Investor Presentation

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Medical to Release Fourth Quarter and Fiscal Year 2016 Financial Results on February 27th

February 14, 2017

MINNEAPOLIS, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Tactile Medical to Ring the Nasdaq Stock Market Opening Bell

January 17, 2017

MINNEAPOLIS, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology Inc. (“Tactile Medical”)... 

Read More >

Upcoming Events

Q4 2016 Tactile Systems Technology, Inc. Earnings Conference Call
Monday, February 27, 2017 5:00 p.m. ET
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet